Chalfont, PA, United States of America

Jackson B Gibbs

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 67(Granted Patents)


Location History:

  • Calfont, PA (US) (1997)
  • Chalfont, PA (US) (1995 - 2006)

Company Filing History:


Years Active: 1995-2006

Loading Chart...
5 patents (USPTO):

Title: Jackson B Gibbs: Innovator in Cancer Treatment

Introduction

Jackson B Gibbs is a notable inventor based in Chalfont, PA (US). He has made significant contributions to the field of cancer treatment, holding a total of 5 patents. His work focuses on innovative methods that combine various therapeutic agents to combat cancer effectively.

Latest Patents

One of his latest patents is a method of treating cancer, which involves using a combination of an antineoplastic agent and an inhibitor of prenyl-protein transferase. This invention outlines methods for administering these therapeutic agents, either sequentially or simultaneously, to achieve optimal treatment outcomes. Additionally, he has worked on patents related to the genes for the subunits of human farnesyl-protein transferase, further contributing to the understanding of cancer treatment mechanisms.

Career Highlights

Throughout his career, Jackson B Gibbs has been associated with prominent organizations such as Merck & Company, Inc. and the Sloan-Kettering Institute for Cancer Research. His work in these institutions has allowed him to advance his research and develop innovative solutions for cancer treatment.

Collaborations

Jackson has collaborated with esteemed colleagues, including Samuel L Graham and Neal Rosen. These partnerships have enriched his research and contributed to the development of his patented methods.

Conclusion

Jackson B Gibbs is a distinguished inventor whose work in cancer treatment has the potential to make a significant impact in the medical field. His innovative approaches and collaborations highlight his commitment to advancing cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…